Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
ONC eNewsletter
A Fox Chase Cancer Center publication for physicians
Oncology News Connection: Winter 2021
Fox Chase Clinical Trial Program Adapts During the COVID-19 Pandemic
Pulsed Low-Dose-Rate Radiation Offers New Treatment Option for Variety of Solid Tumors
Fox Chase Offering Prostate Micro-Ultrasound Technology
CAR T-Cell Therapy Now Available at Fox Chase for Relapsed and Refractory Mantle Cell Lymphoma
Oncology News Connection: Winter 2020
Fox Chase Researchers Actively Recruiting For Breast Cancer Immunotherapy Trials
PARP Inhibitors Now Used for First- and Second-Line Maintenance of Ovarian Cancer
Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care
Multidisciplinary Care, Specialized Clinicians Necessary for Recurrent Sarcoma Treatment
Immunotherapy for Never Smokers with Non-Small Cell Lung Cancer
Oncology News Connection: Summer 2019
The Latest Cellular Immunotherapies Only Available at Certified Cancer Centers
Is Surgery Necessary for Melanoma with Sentinel Node Metastasis?
Delivering an Effective Radiation Dose to Liver Tumors
New Systemic Therapies for Advanced HCC
New Tool Rapidly Matches Patients to Clinical Trials Based on Patient-Specific Eligibility
Oncology News Connection: Winter 2019
De-escalating Treatment for Bladder and Prostate Cancers
The Fastest Growing Oncology Population
Men With Metastatic Prostate Cancer Need Genetic Testing
Retroperitoneal Sarcoma’s Radiation Therapy Options Are Expanding
Many Women With Early-Stage Breast Cancer Can Skip Chemotherapy
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this